Case number 1:22-cv-01481
Bayer Intellectual Property GMBH et al v. Epic Pharma, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 16, 2023 | N/A | SECOND REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 12 . (nms) (Entered: 03/16/2023) (0) |
| Mar 16, 2023 | 16 | REDACTED VERSION of 12 Letter, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/16/2023 (nms). (Entered: 03/16/2023) (1) |
| Mar 13, 2023 | N/A | REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 12 . (nms) (Entered: 03/13/2023) (0) |
| Mar 7, 2023 | 13 | STIPULATION of Dismissal with prejudice, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/7/2023 (nms). (Entered: 03/07/2023) (2) |
| Mar 7, 2023 | 14 | SO ORDERED, Granting 13 Stipulation of Dismissal with prejudice (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 3/7/2023. (nms) (Entered: 03/07/2023) (2) |
| Mar 7, 2023 | 15 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2; 10,828,310 B2. (Attachments: # 1 Order)(nms) (Entered: 03/07/2023) (Main Document) (1) |
| Mar 7, 2023 | 15 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2; 10,828,310 B2. (Attachments: # 1 Order)(nms) (Entered: 03/07/2023) (Order) (2) |
| Mar 1, 2023 | 12 | [SEALED] Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding status. (Fahnestock, Derek) Modified on 3/2/2023 (nms). (Entered: 03/01/2023) (0) |
| Feb 24, 2023 | 11 | ORAL ORDER: An answer was due to be filed on 2/22/2023 (see D.I. 10 ), and to date none has been filed. A status letter is due no later than 3 days from the entry of this Order. Ordered by Judge Richard G. Andrews on 2/24/2023. (nms) (Entered: 02/24/2023) (0) |
| Jan 23, 2023 | 10 | Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 1/23/2023 (nms). (Entered: 01/23/2023) (2) |
| Jan 23, 2023 | N/A | SO ORDERED, re 10 Unopposed Motion to Extend Time (*Reset Answer Deadlines: Epic Pharma, LLC answer due 2/22/2023). Signed by Judge Richard G. Andrews on 1/23/2023. (nms) (Entered: 01/23/2023) (0) |
| Dec 2, 2022 | 8 | REQUEST FOR WAIVER of Service sent to Epic Pharma, LLC on November 22, 2022 by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 12/02/2022) (1) |
| Dec 2, 2022 | 9 | WAIVER OF SERVICE returned executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG: For Epic Pharma, LLC waiver sent on 11/22/2022, answer due 1/23/2023. (Fahnestock, Derek) (Entered: 12/02/2022) (1) |
| Nov 16, 2022 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 11/16/2022) (0) |
| Nov 10, 2022 | 1 | COMPLAINT FOR ANDA/PATENT INFRINGEMENT filed against Epic Pharma, LLC ( Filing fee $ 402, receipt number ADEDC-4003378.) - filed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet) (vfm) (Entered: 11/10/2022) (Main Document) (17) |
| Nov 10, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 11/10/2022) (3) |
| Nov 10, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/29/2022. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/29/2025. (vfm) (Entered: 11/10/2022) (1) |
| Nov 10, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2 ;10,828,310 B2. (vfm) (Entered: 11/10/2022) (1) |
| Nov 10, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG. (vfm) (Entered: 11/10/2022) (1) |
| Nov 10, 2022 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (vfm) (Entered: 11/10/2022) (1) |
| Nov 10, 2022 | 7 | Summons Issued as to Epic Pharma, LLC on 11/10/2022. (vfm) (Entered: 11/10/2022) (2) |
| Nov 10, 2022 | 1 | COMPLAINT FOR ANDA/PATENT INFRINGEMENT filed against Epic Pharma, LLC ( Filing fee $ 402, receipt number ADEDC-4003378.) - filed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet) (vfm) (Entered: 11/10/2022) (Exhibit A-B) (30) |
| Nov 10, 2022 | 1 | COMPLAINT FOR ANDA/PATENT INFRINGEMENT filed against Epic Pharma, LLC ( Filing fee $ 402, receipt number ADEDC-4003378.) - filed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet) (vfm) (Entered: 11/10/2022) (Civil Cover Sheet) (1) |
